197 related articles for article (PubMed ID: 37391533)
1. Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas.
Ettlin J; Bauer A; Opitz L; Malbon A; Markkanen E
J Mammary Gland Biol Neoplasia; 2023 Jul; 28(1):14. PubMed ID: 37391533
[TBL] [Abstract][Full Text] [Related]
2. Next-generation RNA sequencing of FFPE subsections reveals highly conserved stromal reprogramming between canine and human mammary carcinoma.
Amini P; Nassiri S; Ettlin J; Malbon A; Markkanen E
Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31308057
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
4. Identification of disease-promoting stromal components by comparative proteomic and transcriptomic profiling of canine mammary tumors using laser-capture microdissected FFPE tissue.
Pöschel A; Beebe E; Kunz L; Amini P; Guscetti F; Malbon A; Markkanen E
Neoplasia; 2021 Apr; 23(4):400-412. PubMed ID: 33794398
[TBL] [Abstract][Full Text] [Related]
5. Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components.
Amini P; Nassiri S; Malbon A; Markkanen E
Sci Rep; 2020 Mar; 10(1):5506. PubMed ID: 32218455
[TBL] [Abstract][Full Text] [Related]
6. Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.
Markkanen E
Front Cell Dev Biol; 2019; 7():348. PubMed ID: 31921858
[TBL] [Abstract][Full Text] [Related]
7. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
[TBL] [Abstract][Full Text] [Related]
8. SFRP1 Expression is Inversely Associated With Metastasis Formation in Canine Mammary Tumours.
Seitz J; Bilsland A; Puget C; Baasner I; Klopfleisch R; Stein T
J Mammary Gland Biol Neoplasia; 2023 Jul; 28(1):15. PubMed ID: 37402051
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.
Hussain S; Saxena S; Shrivastava S; Mohanty AK; Kumar S; Singh RJ; Kumar A; Wani SA; Gandham RK; Kumar N; Sharma AK; Tiwari AK; Singh RK
PLoS One; 2018; 13(12):e0208656. PubMed ID: 30517191
[TBL] [Abstract][Full Text] [Related]
10. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
13. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL
Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
16. Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland.
Dolka I; Czopowicz M; Stopka D; Wojtkowska A; Kaszak I; Sapierzyński R
Sci Rep; 2024 Mar; 14(1):5569. PubMed ID: 38448646
[TBL] [Abstract][Full Text] [Related]
17. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
18. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Hyperplasia, Neoplasia and Supporting Stroma.
Levi M; Brunetti B; Sarli G; Benazzi C
J Comp Pathol; 2016 Nov; 155(4):277-285. PubMed ID: 27528038
[TBL] [Abstract][Full Text] [Related]
20. p62/SQSTM1 expression in canine mammary tumours: Evolutionary notes.
Mariotti F; Magi GE; Gavazza A; Vincenzetti S; Komissarov A; Shneider A; Venanzi FM
Vet Comp Oncol; 2019 Dec; 17(4):570-577. PubMed ID: 31332942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
